New tool makes immune therapy more effective in prostate cancer

Prostate crab is often resistant to immunotherapy, which harnesses a person's immune strategy to admit and destruct tumors. But a caller exertion that targets RNA successful crab cells gave immunotherapy caller life, improving its quality to unleash cancer-killing cells successful laboratory studies.